Clinical practice should increasingly focus on: Body composition assessment Adequate protein intake Resistance exercise Strategies to preserve skeletal muscle during weight loss #GLP1 #Obesity #Sarcopenia #ClinicalNutrition #BodyComposition #MuscleHealth #ObesityMedicine To view or add a comment, sign in I think we will have a frailty problem in the future, especially with the cyclic use of these meds
Store lyophilized AOD9604 at -20C
& Pacini, G
Individuals taking multiple antihypertensive agents particularly alpha-blockers, vasodilators, diuretics, SGLT2 inhibitors, tricyclic antidepressants, antipsychotics, nitrates, PDE5 inhibitors, or centrally acting antihypertensivesare at heightened risk, as the blood pressure-lowering effects of these medications may be potentiated by weight loss and volume changes associated with tirzepatide therapy
Out-of-Pocket Costs Without Coverage If you don't qualify for the GLP-1 Bridge or prefer not to wait until July 2026, here's what you can expect to pay out of pocket in 2026: Approximate Monthly Costs (Without Insurance) Ozempic: ~$199-$499/month through manufacturer savings programs (list price ~$998) Wegovy: ~$149-$199/month through savings programs (list price ~$1,350) Zepbound: ~$349/month through LillyDirect (list price ~$1,060) Mounjaro: ~$349/month through LillyDirect (list price ~$1,060) Freedom and Legacy Advisors St
